These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19546812)

  • 1. CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia.
    Chi BH; Giganti M; Mulenga PL; Limbada M; Reid SE; Mutale W; Stringer JS
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):125-31. PubMed ID: 19546812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia.
    Koethe JR; Limbada MI; Giganti MJ; Nyirenda CK; Mulenga L; Wester CW; Chi BH; Stringer JS
    AIDS; 2010 Aug; 24(13):2117-21. PubMed ID: 20543657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
    Stringer JS; Zulu I; Levy J; Stringer EM; Mwango A; Chi BH; Mtonga V; Reid S; Cantrell RA; Bulterys M; Saag MS; Marlink RG; Mwinga A; Ellerbrock TV; Sinkala M
    JAMA; 2006 Aug; 296(7):782-93. PubMed ID: 16905784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.
    Moore DM; Harris R; Lima V; Hogg B; May M; Yip B; Justice A; Mocroft A; Reiss P; Lampe F; Chêne G; Costagliola D; Elzi L; Mugavero MJ; Monforte AD; Sabin C; Podzamczer D; Fätkenheuer G; Staszewski S; Gill J; Sterne JA;
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):357-63. PubMed ID: 19668084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.
    Chi BH; Cantrell RA; Zulu I; Mulenga LB; Levy JW; Tambatamba BC; Reid S; Mwango A; Mwinga A; Bulterys M; Saag MS; Stringer JS
    Int J Epidemiol; 2009 Jun; 38(3):746-56. PubMed ID: 19223334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
    Bolton-Moore C; Mubiana-Mbewe M; Cantrell RA; Chintu N; Stringer EM; Chi BH; Sinkala M; Kankasa C; Wilson CM; Wilfert CM; Mwango A; Levy J; Abrams EJ; Bulterys M; Stringer JS
    JAMA; 2007 Oct; 298(16):1888-99. PubMed ID: 17954540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa.
    Hoffmann CJ; Schomaker M; Fox MP; Mutevedzi P; Giddy J; Prozesky H; Wood R; Garone DB; Egger M; Boulle A;
    J Acquir Immune Defic Syndr; 2013 May; 63(1):34-41. PubMed ID: 23344547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
    Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
    Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/microL.
    Moore DM; Hogg RS; Yip B; Craib K; Wood E; Montaner JS
    HIV Med; 2006 Sep; 7(6):383-8. PubMed ID: 16903983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
    Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort.
    Takuva S; Maskew M; Brennan AT; Long L; Sanne I; Fox MP
    J Int AIDS Soc; 2014; 17(1):18651. PubMed ID: 24594114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
    McGrath N; Lessells RJ; Newell ML
    HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.
    Rohr JK; Ive P; Horsburgh CR; Berhanu R; Shearer K; Maskew M; Long L; Sanne I; Bassett J; Ebrahim O; Fox MP
    PLoS One; 2016; 11(8):e0161469. PubMed ID: 27548695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.
    Gutierrez F; Padilla S; Masiá M; Iribarren JA; Moreno S; Viciana P; Muñoz L; Gómez Sirvent JL; Vidal F; López-Aldeguer J; Blanco JR; Leal M; Rodríguez-Arenas MA; Perez Hoyos S;
    PLoS One; 2006 Dec; 1(1):e89. PubMed ID: 17183720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.
    Moore DM; Hogg RS; Braitstein P; Wood E; Yip B; Montaner JS
    Antivir Ther; 2006; 11(1):125-9. PubMed ID: 16518968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia.
    Vinikoor MJ; Joseph J; Mwale J; Marx MA; Goma FM; Mulenga LB; Stringer JS; Eron JJ; Chi BH
    AIDS Res Hum Retroviruses; 2014 Oct; 30(10):949-55. PubMed ID: 24998881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling adverse treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics in Lusaka.
    Fwemba I; Musonda P
    Public Health; 2017 Jun; 147():8-14. PubMed ID: 28404502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.